Skip to content

Released Nov 2, 2023, after the close

10-Q filed Nov 6, 2023, 37 days after period end · 0001636422-23-000133

Q3 2023 · 10-Q
Revenue$73.77M+7.9% vs Q3 2022+0.8% vs Q2 2023
Net Income-$22.03MN/M vs Q3 2022N/M vs Q2 2023
EPS Diluted-$0.39N/M vs Q3 2022N/M vs Q2 2023
Operating Income-$24,580,000N/M
Operating Cash Flowderived$3,115,000N/M
Free Cash Flowderived$2,966,000N/M
Margins · derived
Operating margin-33.3%+33.6 pt vs Q3 2022
Net margin-29.9%+37.0 pt vs Q3 2022

What the release said

The release

Same quarter

MetricQ3 2023Q3 2022Q3 2021Q3 2020
Revenue$73.77M$68.35M$61.74M$47.19M
Net Income-$22.03M-$45.74M-$40.01M-$27.33M
EPS Diluted-$0.39-$0.84-$0.82-$0.68

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR